• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铜绿假单胞菌中通过 uL4 和 uL22 核糖体突变产生的大环内酯类耐药性。

Macrolide resistance through uL4 and uL22 ribosomal mutations in Pseudomonas aeruginosa.

机构信息

Department of Clinical Microbiology 9301, Rigshospitalet, 2100, Copenhagen, Denmark.

The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800, Kgs. Lyngby, Denmark.

出版信息

Nat Commun. 2024 Oct 16;15(1):8906. doi: 10.1038/s41467-024-53329-8.

DOI:10.1038/s41467-024-53329-8
PMID:39414850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11484784/
Abstract

Macrolides are widely used antibiotics for the treatment of bacterial airway infections. Due to its elevated minimum inhibitory concentration in standardized culture media, Pseudomonas aeruginosa is considered intrinsically resistant and, therefore, antibiotic susceptibility testing against macrolides is not performed. Nevertheless, due to macrolides' immunomodulatory effect and suppression of virulence factors, they are used for the treatment of persistent P. aeruginosa infections. Here, we demonstrate that macrolides are, instead, effective antibiotics against P. aeruginosa airway infections in an Air-Liquid Interface (ALI) infection model system resembling the human airways. Importantly, macrolide treatment in both people with cystic fibrosis and primary ciliary dyskinesia patients leads to the accumulation of uL4 and uL22 ribosomal protein mutations in P. aeruginosa which causes antibiotic resistance. Consequently, higher concentrations of antibiotics are needed to modulate the macrolide-dependent suppression of virulence. Surprisingly, even in the absence of antibiotics, these mutations also lead to a collateral reduction in growth rate, virulence and pathogenicity in airway ALI infections which are pivotal for the establishment of a persistent infection. Altogether, these results lend further support to the consideration of macrolides as de facto antibiotics against P. aeruginosa and the need for resistance monitoring upon prolonged macrolide treatment.

摘要

大环内酯类抗生素被广泛用于治疗细菌性气道感染。由于其在标准化培养介质中的最低抑菌浓度升高,铜绿假单胞菌被认为具有固有耐药性,因此,不对大环内酯类抗生素进行药敏试验。然而,由于大环内酯类药物具有免疫调节作用和抑制毒力因子的作用,它们被用于治疗持续性铜绿假单胞菌感染。在这里,我们证明在类似于人类气道的气液界面(ALI)感染模型系统中,大环内酯类药物是治疗铜绿假单胞菌气道感染的有效抗生素。重要的是,大环内酯类药物治疗囊性纤维化患者和原发性纤毛运动障碍患者会导致铜绿假单胞菌中 uL4 和 uL22 核糖体蛋白突变的积累,从而导致抗生素耐药性。因此,需要更高浓度的抗生素来调节大环内酯类药物依赖性的毒力抑制。令人惊讶的是,即使没有抗生素,这些突变也会导致气道 ALI 感染中的生长速度、毒力和致病性的附带降低,这对于持续性感染的建立至关重要。总之,这些结果进一步支持将大环内酯类药物视为铜绿假单胞菌的事实上的抗生素,并需要在长期大环内酯类药物治疗时监测耐药性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dad7/11484784/2cb7994dbde5/41467_2024_53329_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dad7/11484784/3463a42e6ecf/41467_2024_53329_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dad7/11484784/7169358f04a2/41467_2024_53329_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dad7/11484784/901274da6fc9/41467_2024_53329_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dad7/11484784/5718d3f4915d/41467_2024_53329_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dad7/11484784/2cb7994dbde5/41467_2024_53329_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dad7/11484784/3463a42e6ecf/41467_2024_53329_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dad7/11484784/7169358f04a2/41467_2024_53329_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dad7/11484784/901274da6fc9/41467_2024_53329_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dad7/11484784/5718d3f4915d/41467_2024_53329_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dad7/11484784/2cb7994dbde5/41467_2024_53329_Fig5_HTML.jpg

相似文献

1
Macrolide resistance through uL4 and uL22 ribosomal mutations in Pseudomonas aeruginosa.铜绿假单胞菌中通过 uL4 和 uL22 核糖体突变产生的大环内酯类耐药性。
Nat Commun. 2024 Oct 16;15(1):8906. doi: 10.1038/s41467-024-53329-8.
2
Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance.大环内酯类治疗铜绿假单胞菌感染会导致 uL4 核糖体蛋白突变,从而产生高水平耐药性。
Clin Microbiol Infect. 2022 Dec;28(12):1594-1601. doi: 10.1016/j.cmi.2022.08.003. Epub 2022 Aug 19.
3
Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors.大环内酯类药物对细菌毒力的调节作用:作为群体感应抑制剂的潜在作用。
Curr Pharm Des. 2004;10(25):3055-65. doi: 10.2174/1381612043383377.
4
Acquired resistance to macrolides in from cystic fibrosis patients.来自囊性纤维化患者的 中对大环内酯类药物的获得性耐药。
Eur Respir J. 2017 May 19;49(5). doi: 10.1183/13993003.01847-2016. Print 2017 May.
5
Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance: author's response.铜绿假单胞菌感染中的大环内酯类治疗导致uL4核糖体蛋白突变,从而产生高水平耐药性:作者回应。
Clin Microbiol Infect. 2022 Dec;28(12):1667-1668. doi: 10.1016/j.cmi.2022.09.010. Epub 2022 Sep 20.
6
Characterization of Two Macrolide Resistance-Related Genes in Multidrug-Resistant Isolates.大环内酯类耐药相关基因在多药耐药株中的特征。
Pol J Microbiol. 2020 Sep;69(3):349-356. doi: 10.33073/pjm-2020-038. Epub 2020 Sep 8.
7
Re: 'Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance' by Goltermann et al.关于:戈尔特尔曼等人所著的《铜绿假单胞菌感染中的大环内酯类治疗导致uL4核糖体蛋白突变并引发高水平耐药》
Clin Microbiol Infect. 2022 Dec;28(12):1665-1666. doi: 10.1016/j.cmi.2022.08.022. Epub 2022 Sep 6.
8
Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.铜绿假单胞菌在囊性纤维化患者中的慢性定植。
Curr Opin Pediatr. 2007 Feb;19(1):83-8. doi: 10.1097/MOP.0b013e3280123a5d.
9
TpiA is a Key Metabolic Enzyme That Affects Virulence and Resistance to Aminoglycoside Antibiotics through CrcZ in Pseudomonas aeruginosa.TpiA 是一种关键代谢酶,通过铜绿假单胞菌中的 CrcZ 影响毒力和对氨基糖苷类抗生素的耐药性。
mBio. 2020 Jan 7;11(1):e02079-19. doi: 10.1128/mBio.02079-19.
10
Mutations in 23S rRNA confer resistance against azithromycin in Pseudomonas aeruginosa.23S rRNA 突变使铜绿假单胞菌对阿奇霉素产生耐药性。
Antimicrob Agents Chemother. 2012 Aug;56(8):4519-21. doi: 10.1128/AAC.00630-12. Epub 2012 May 29.

本文引用的文献

1
Metabolic specialization drives reduced pathogenicity in Pseudomonas aeruginosa isolates from cystic fibrosis patients.代谢特化导致囊性纤维化患者分离的铜绿假单胞菌的致病性降低。
PLoS Biol. 2024 Aug 23;22(8):e3002781. doi: 10.1371/journal.pbio.3002781. eCollection 2024 Aug.
2
Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance.MexZ 外排泵调节剂的突变将铜绿假单胞菌的组织定殖状态转变为抗生素耐受状态。
Nat Commun. 2024 Mar 22;15(1):2584. doi: 10.1038/s41467-024-46938-w.
3
Macrolide antibiotics (including azithromycin) for cystic fibrosis.
大环内酯类抗生素(包括阿奇霉素)治疗囊性纤维化。
Cochrane Database Syst Rev. 2024 Feb 27;2(2):CD002203. doi: 10.1002/14651858.CD002203.pub5.
4
Development of a novel air-liquid interface airway tissue equivalent model for in vitro respiratory modeling studies.开发一种新型的气液界面气道组织等效模型,用于体外呼吸建模研究。
Sci Rep. 2023 Jun 22;13(1):10137. doi: 10.1038/s41598-023-36863-1.
5
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.全球慢性阻塞性肺疾病倡议 2023 年报告:GOLD 执行摘要。
Eur Respir J. 2023 Apr 1;61(4). doi: 10.1183/13993003.00239-2023. Print 2023 Apr.
6
Evaluating Bacterial Pathogenesis Using a Model of Human Airway Organoids Infected with Pseudomonas aeruginosa Biofilms.使用感染铜绿假单胞菌生物膜的人呼吸道类器官模型评估细菌发病机制。
Microbiol Spectr. 2022 Dec 21;10(6):e0240822. doi: 10.1128/spectrum.02408-22. Epub 2022 Oct 27.
7
Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance: author's response.铜绿假单胞菌感染中的大环内酯类治疗导致uL4核糖体蛋白突变,从而产生高水平耐药性:作者回应。
Clin Microbiol Infect. 2022 Dec;28(12):1667-1668. doi: 10.1016/j.cmi.2022.09.010. Epub 2022 Sep 20.
8
Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance.大环内酯类治疗铜绿假单胞菌感染会导致 uL4 核糖体蛋白突变,从而产生高水平耐药性。
Clin Microbiol Infect. 2022 Dec;28(12):1594-1601. doi: 10.1016/j.cmi.2022.08.003. Epub 2022 Aug 19.
9
Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics.铜绿假单胞菌:发病机制、毒力因子、抗生素耐药性、与宿主的相互作用、技术进展和新兴治疗方法。
Signal Transduct Target Ther. 2022 Jun 25;7(1):199. doi: 10.1038/s41392-022-01056-1.
10
Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution.持续性细菌感染、抗生素治疗失败与微生物适应性进化
Antibiotics (Basel). 2022 Mar 21;11(3):419. doi: 10.3390/antibiotics11030419.